证券日报网讯1月27日，稳健医疗（300888）在互动平台回答投资者提问时表示，公司将严格依据《深 圳证券交易所创业板股票上市规则》等相关规定，结合公司实际情况判断并履行信息披露义务。 ...

Core Viewpoint - The company is actively addressing the market demand arising from an aging society by developing and promoting products in the fields of incontinence care and chronic wound care [2] Group 1: Product Development - The company has established a sub-brand "Light Skin Care" for adult incontinence products and is focusing on chronic wound care products such as silicone gel dressings and foam dressings [2] - Continuous product research and development, as well as market promotion, are being prioritized to meet the needs of the aging population [2] Group 2: Strategic Partnerships - The company emphasizes collaboration opportunities with civil affairs departments and elderly care institutions to align products with relevant policies and facilitate channel connections [2] Group 3: Future Plans - The company plans to steadily expand its range of elderly care products, enhance technological research and development, and rationally plan production capacity based on market conditions [2]

Market Overview - The personal care products sector experienced a decline of 1.53% on January 27, with Yanjiang Co., Ltd. leading the drop [1] - The Shanghai Composite Index closed at 4139.9, up 0.18%, while the Shenzhen Component Index closed at 14329.91, up 0.09% [1] Stock Performance - Notable stock performances include: - Dengkang Oral Care (001328) closed at 40.93, up 1.99% with a trading volume of 15,900 shares and a turnover of 64.67 million yuan [1] - Beijia Clean (603059) closed at 35.52, up 0.45% with a trading volume of 22,500 shares and a turnover of 79.75 million yuan [1] - Yanjiang Co., Ltd. (300658) closed at 17.49, down 6.02% with a trading volume of 404,000 shares and a turnover of 702 million yuan [2] Capital Flow - The personal care products sector saw a net outflow of 73.09 million yuan from institutional investors, while retail investors had a net inflow of 85.19 million yuan [2] - The capital flow for individual stocks shows: - Zhongshun Jierou (002511) had a net inflow of 4.92 million yuan from retail investors, but a net outflow of 1.30 million yuan from institutional investors [3] - Other stocks like Yiyi Co., Ltd. (001206) and Jeya Co., Ltd. (301108) also experienced significant net outflows from institutional investors [3]

稳健医疗首次公开发行股票发行费用为1.56亿元，其中，承销保荐费1.23亿元。 稳健医疗2023年5月27日披露的2022年年度权益分派实施公告显示，公司以扣除回购股份后的 419,737,649股为基数，向全体股东拟每10股派发现金股利19.00元含税),每10股转增股本4股，不送红 股。 中国经济网北京1月27日讯稳健医疗（300888）(300888.SZ)今日股价下跌，截至收盘，该股报37.00元， 跌幅1.62%。该股目前处于破发状态。 稳健医疗2020年9月17日在深交所创业板上市，发行新股数量为5000万股，发行价格74.30元/股，保荐 机构为中国国际金融股份有限公司，保荐代表人为沈璐璐、王浩楠 稳健医疗首次公开发行股票募集资金总额为37.15亿元，扣除发行费用后，募集资金净额为35.59亿元。 稳健医疗最终募集资金净额较原计划多21.33亿元。稳健医疗于2020年9月11日发布的招股说明书显示， 该公司计划募集资金14.26亿元，分别用于高端敷料生产线建设项目、营销网络建设项目、研发中心建 设项目、数字化管理系统项目。 ...

Core Viewpoint - The company is actively addressing the market demand arising from an aging population by developing and promoting elderly care products, while also focusing on collaboration with relevant authorities and institutions to adapt to policy changes [1]. Group 1: Product Development and Market Strategy - The company has established a presence in the elderly care product sector, specifically in adult incontinence care under the "Light Skin Care" brand and chronic wound care with silicone gel and foam dressings [1]. - Continuous product research and market promotion efforts are being undertaken to enhance the company's offerings in the elderly care segment [1]. Group 2: Collaboration and Policy Adaptation - The company emphasizes the importance of partnerships with civil affairs departments and elderly care institutions to ensure product alignment with relevant subsidy policies [1]. - Active progress is being made in channel integration with these institutions to facilitate the distribution of elderly care products [1]. Group 3: Future Planning and Capacity - The company plans to steadily expand its elderly care product categories and strengthen technological research and development based on market demand and its own advantages [1]. - Capacity planning will be conducted in a reasonable manner according to market conditions [1].

证券日报网1月26日讯，稳健医疗（300888）在接受调研者提问时表示，作为"品牌展示的主阵地，产品 营销的主战场"，全棉时代重视线下门店的发展与经营质量。2026年门店渠道将坚持高质量发展的策 略，一方面"经营好店"，聚焦现有门店提升品质、优化效率；第二"开好店"，积极审慎地拓展新店；第 三，推进门店新零售一体化作战，线上线下（300959）相互融合。门店效率提升举措主要体现在三方 面：一是做好门店形象升级工作，当前公司正推进核心门店从道具门头到导购人员的全方位形象优化， 未来还将通过精选核心大店进一步升级形象，提升消费者到店购物体验；第二，会员服务将继续升级， 后续公司将重点升级会员权益，尤其针对高价值会员，并以"发自内心、一致性、超值超预期"为服务三 要素，为会员提供更优质服务；第三，积极拥抱包括即时零售在内的新零售渠道，推进线上线下一体 化、社群融合一体化、到店到家一体化，相互赋能带动增量。综上，公司计划努力推进上述举措，进而 带动门店业绩增长。 ...

Market Overview - The personal care products sector experienced a decline of 0.16% on January 26, with Beijia leading the drop [1] - The Shanghai Composite Index closed at 4132.61, down 0.09%, while the Shenzhen Component Index closed at 14316.64, down 0.85% [1] Stock Performance - Notable stock performances include: - Yanjing Co. (300658) closed at 18.61, up 2.14% with a trading volume of 489,900 shares and a transaction value of 917 million yuan [1] - Stable Medical (300888) closed at 37.61, up 1.81% with a trading volume of 86,900 shares and a transaction value of 326 million yuan [1] - Beijia (603059) closed at 35.36, down 5.07% with a trading volume of 25,900 shares and a transaction value of 92.56 million yuan [2] Capital Flow - The personal care products sector saw a net inflow of 72.66 million yuan from institutional investors, while retail investors experienced a net outflow of 72.01 million yuan [2] - The capital flow for individual stocks includes: - Yanjing Co. had a net inflow of 10.5 million yuan from institutional investors [3] - Stable Medical had a net inflow of 12.15 million yuan from institutional investors [3] - Beijia experienced a net outflow of 5.37 million yuan from institutional investors [3]

Core Viewpoint - The company aims for "decisive growth" in its medical sector by 2026, emphasizing "product leadership" as the foundation of its strategy [2] Group 1: Strategic Focus - The core strategy revolves around "product leadership, operational excellence, brand enhancement, and digital intelligence empowerment" [2] - The company plans to execute three key battles: focusing on strategic product breakthroughs, enhancing its omnichannel layout domestically and internationally, and integrating newly acquired companies [2] Group 2: Growth Drivers - Growth in the medical sector will be driven by both organic and external acquisitions [2] - On the organic side, the company will optimize its product structure and promote high-margin, high-growth categories while expanding into overseas markets and various domestic channels [2] - The acquisition of the U.S. company GRI in 2024 has provided valuable overseas channel resources, customer resources, and production capacity, facilitating smooth integration and supply chain transitions [2] Group 3: Future Goals - By 2026, the company will focus on transforming its products into high-value offerings and its business model into a brand-oriented approach, while continuously expanding its overseas market presence [2] - The company aims to achieve revenue growth targets set by equity incentives and further enhance profit margins [2]

（文章来源：证券日报） 证券日报网1月26日讯 ，稳健医疗在接受调研者提问时表示，2026年开年，公司召开了面向全集团的战 略宣贯大会，大会以"产品领先，卓越运营，品牌向上，数智赋能"为主题，向全体员工明确未来三年战 略方向与2026年经营计划。公司始终坚持医疗业务和消费品业务同步发展，未来将保持战略定力，持续 深耕主业，走高质量发展之路。在业绩目标方面，收入端将朝着股权激励设定的目标持续努力。盈利能 力方面，两大主业持续通过产品创新迭代、优化产品结构、提升渠道管理质量、降本增效、提升投放效 率、加强品牌建设等措施，稳步提升盈利水平。面向2026年，公司上下众志成城，信心满满，将努力沿 着既定战略目标持续努力。中长期来看，公司坚持长期主义发展理念，公司一直重视保障股东投资利 益，希望通过良好的经营成绩及稳定的分红政策回报股东的长期支持。 ...

证券日报网1月26日讯 ，稳健医疗在接受调研者提问时表示，公司重视股东回报，上市后每年坚持现金 分红，分红金额占归母净利润比例也在逐年提升。截至2025年中期，公司累计现金分红28.8亿元，回购 股份支付现金6.9亿元，两项合计占首发募集资金净额的100.3%。未来，公司将根据每年的利润情况、 企业成长性和战略发展计划综合评估分红比例，努力保持稳定的分红水平。 （文章来源：证券日报） ...